Comments on: “The Next Hyper Growth Stock” http://www.stockgumshoe.com/2008/05/the-next-hyper-growth-stock.html Frustrated or intrigued by email teasers from investment newsletters and advisers? We solve them and track their performance here ... so stick around, participate and subscribe (it's free)! Sat, 21 Nov 2009 05:52:09 -0600 http://wordpress.org/?v=2.8.4 hourly 1 By: John Wilson http://www.stockgumshoe.com/2008/05/the-next-hyper-growth-stock.html/comment-page-1#comment-3316 John Wilson Mon, 02 Jun 2008 07:45:23 +0000 http://www.stockgumshoe.com/2008/05/the-next-hyper-growth-stock.html#comment-3316 The key to success with this technology is two fold 1) reimbursement for the scan and b) the willingness of dermatologists in USA to use as a a primary tool for melanoma diagnosis.( Or at least support its use in Primary care). Melanoma diagnosis in the dermatologists eyes is not difficult and their sensitivity and specificity for diagnosis is very high. The excisions are reimbursed as standard and dermatologists with a potentially deadly disease on their hands will err on the side of caution and excise; as clinical practice coupled with reimbursement rates make it the best move. However if this technology is used in primary care as a screener then it may have merit as primary care diagnosis is poor for melanoma. Readers should be aware that no diagnostic test is 100% accurate and the sensitivity of Melafind is 98% with specificity of 45% - compare with other automatic diagnostic machines that are of the order of 96% sens with 83% specificity. It has been around for a while, is still in phase III and I wonder if the FDA will be happy releasing to general primary care market with less than 100% sensitivity coupled with a high specificity for this deadly disease. I am unsure whether they have as yet got any data to support reduction in biopsy rates which will be core to their pitch. The key to success with this technology is two fold 1) reimbursement for the scan and b) the willingness of dermatologists in USA to use as a a primary tool for melanoma diagnosis.( Or at least support its use in Primary care). Melanoma diagnosis in the dermatologists eyes is not difficult and their sensitivity and specificity for diagnosis is very high. The excisions are reimbursed as standard and dermatologists with a potentially deadly disease on their hands will err on the side of caution and excise; as clinical practice coupled with reimbursement rates make it the best move. However if this technology is used in primary care as a screener then it may have merit as primary care diagnosis is poor for melanoma. Readers should be aware that no diagnostic test is 100% accurate and the sensitivity of Melafind is 98% with specificity of 45% – compare with other automatic diagnostic machines that are of the order of 96% sens with 83% specificity. It has been around for a while, is still in phase III and I wonder if the FDA will be happy releasing to general primary care market with less than 100% sensitivity coupled with a high specificity for this deadly disease. I am unsure whether they have as yet got any data to support reduction in biopsy rates which will be core to their pitch.

]]> By: DAVID HATHAWAY http://www.stockgumshoe.com/2008/05/the-next-hyper-growth-stock.html/comment-page-1#comment-3234 DAVID HATHAWAY Mon, 26 May 2008 12:29:40 +0000 http://www.stockgumshoe.com/2008/05/the-next-hyper-growth-stock.html#comment-3234 Apologies for the typo and grammatical mistakes in previous posting. I'll work on my editing skills. david Apologies for the typo and grammatical mistakes
in previous posting. I’ll work on my editing
skills.

david

]]> By: DAVID HATHAWAY http://www.stockgumshoe.com/2008/05/the-next-hyper-growth-stock.html/comment-page-1#comment-3233 DAVID HATHAWAY Mon, 26 May 2008 12:26:09 +0000 http://www.stockgumshoe.com/2008/05/the-next-hyper-growth-stock.html#comment-3233 SAGENOT, Having had pentuple bypass "slice & dice" I want to know how you learn what type of plaque you have and does the chelation therapy affected all blood vessels or are just the heart arteries targeted? ALL OF YOU Looking for a online calculator that will let me set a monthly deposit, interest rate and time. The calculator will give me the accumulated amount. Don't know the correct term to use, but it close to a sinking fund but the ones I found did not let me set the deposit. Help? david SAGENOT,

Having had pentuple bypass “slice & dice” I want to know how you learn what type of plaque you have and
does the chelation therapy affected all blood vessels or are just the heart arteries targeted?

ALL OF YOU

Looking for a online calculator that will let me
set a monthly deposit, interest rate and time.
The calculator will give me the accumulated amount.
Don’t know the correct term to use, but it close to a sinking fund but the ones I found did not let me
set the deposit. Help?

david

]]> By: sandelm http://www.stockgumshoe.com/2008/05/the-next-hyper-growth-stock.html/comment-page-1#comment-3230 sandelm Mon, 26 May 2008 02:20:49 +0000 http://www.stockgumshoe.com/2008/05/the-next-hyper-growth-stock.html#comment-3230 This is for farley5. Recently I became interesteed in the less publicised alternative treatments. Could you please give me some more details about the anti-skin cancer cream you mentioned above? If you want, you can email them to sandelm@yahoo.com. Thanks. This is for farley5. Recently I became interesteed in the less publicised alternative treatments. Could you please give me some more details about the anti-skin cancer cream you mentioned above? If you want, you can email them to sandelm@yahoo.com. Thanks.

]]> By: SageNot http://www.stockgumshoe.com/2008/05/the-next-hyper-growth-stock.html/comment-page-1#comment-3228 SageNot Sun, 25 May 2008 17:32:06 +0000 http://www.stockgumshoe.com/2008/05/the-next-hyper-growth-stock.html#comment-3228 http://finance.yahoo.com/echarts?s=MELA#symbol=MELA;range=2y I'm just killing time between church & the BbQ at the pool this afternoon & began reading the MELA Yahoo board postings. A pretty deep board I must say, & I'm wondering what Investment Letter, that charges $2,500./yr, used MELA as the tease? Makes yah wonder when the Access Group from Marc Lichtenfeld (I might've erred here, Marc edits Smart Profits for $99./yr or less) & The Motely Fool use MELA in their regular less expensive publications. http://finance.yahoo.com/echarts?s=MELA#symbol=MELA;range=2y

I’m just killing time between church & the BbQ at the pool this afternoon & began reading the MELA Yahoo board postings. A pretty deep board I must say, & I’m wondering what Investment Letter, that charges $2,500./yr, used MELA as the tease? Makes yah wonder when the Access Group from Marc Lichtenfeld (I might’ve erred here, Marc edits Smart Profits for $99./yr or less) & The Motely Fool use MELA in their regular less expensive publications.

]]>